IMR Press / FBL / Volume 16 / Issue 2 / DOI: 10.2741/3696

Frontiers in Bioscience-Landmark (FBL) is published by IMR Press from Volume 26 Issue 5 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with Frontiers in Bioscience.

Open Access Article
A minireview: the role of MAPK/ERK and PI3K/Akt pathways in thyroid follicular cell-derived neoplasm
Show Less
1 Department of Molecular Bases of Medicine, Medical University of Lodz, Pomorska St 251, 92-213 Lodz, Poland. ewa.brzezianska@umed.lodz.pl
Academic Editor:Anna Czarnecka
Front. Biosci. (Landmark Ed) 2011, 16(2), 422–439; https://doi.org/10.2741/3696
Published: 1 January 2011
(This article belongs to the Special Issue Frontiers in molecular medicine)
Abstract

The MAPK/ERK (mitogen - activated protein kinase/extracellular signal-regulated kinase signaling pathway) and PI3K/Akt (lipid kinase phoshoinositide-3-kinase signaling pathway) play an important role in transmission of cell signals through transduction systems (ligands, transmembrane receptors and cytoplasmic secondary messengers) to cell nucleus, where they influence the expression of genes that regulate important cellular processes: cell growth, proliferation and apoptosis. The genes, coding the signaling cascade proteins (e.g., RET, RAS, BRAF, PI3K, PTEN, AKT), are mutated or aberrantly expressed in thyroid cancer derived from follicular thyroid cell. Genetic and epigenetic alternations, concerning MAPK/ERK and PI3K/Akt signaling pathways, contribute to their activation and interaction in consequence of malignant follicular cell transformation. This review is focused mainly on genetic alterations in genes, coding signaling pathway proteins. Moreover, it is additionally pointed out that genetic, as well as epigenetic DNA changing via aberrant methylation of several tumour suppressor and thyroid-specific genes are associated with tumour aggressiveness, being a jointly responsible mechanism for thyroid tumorigenesis. The understanding of this molecular mechanism provides access to novel molecular therapeutic strategies for inhibiting oncogenic activity of signaling pathways.

Share
Back to top